Objective: Benchmarking uses best performance in a given field as reference point for others to improve. Surgical benchmarks -best achievable results -were recently introduced in outcome research. Our aim was to identify the global benchmarks for bariatric surgery (BS) (Roux-en-Y gastric bypass [RYGB] and sleeve gastrectomy [SG] ). Methods: The establishment of BS benchmarks followed a standardized methodology, previously applied for liver surgery and esophagectomy. Out of 39424 elective bariatric procedures performed in 19 high volume academic centers on 3 continents between 06/2012-05/2017, we identified 4120 RYGB and 1457 SG benchmark cases based on preoperative risk-factors (Fig. 1) . Benchmark patients had no: previous abdominal surgery, concomitant procedures, diabetes, sleep apnea, cardiopathy, renal insufficiency, IBD, immunosuppression, anti-coagulation, BMI > 50kg/m 2 , age > 65 years and were followed-up for minimum 90-days. We chose clinically relevant endpoints covering intra-and postoperative course, with a focus on complications graded by severity, using the Clavien-Dindo classification and the comprehensive complication index (CCI ® ). Benchmark cut-offs were set at the 75 th percentile of the included centers' median value for respective outcomes (R software). Results: BS patients were mainly females (78%), aged 38 ± 11 years, with a baseline BMI of 40.8 ± 5.8 kg/m 2 . Benchmark cutoffs for surgical quality indicators are presented in Table 1 for RYGB, and in Table 2 for SG. During the first 90-days, 7.2% of RYGB and 6.2% of SG patients presented at least 1 complication. For RYGB and SG alike, most readmissions occurred beyond 90-days (Fig.  2) , and were most frequently due to symptomatic cholelithiasis or abdominal pain of unknown origin (Fig. 3) . Conclusion: Benchmark cutoffs targeting peri-operative outcomes in BS offer a new tool in surgical quality-metrics and may be implemented in the quality-improvement cycle. In high-volume centers, the 90-day postoperative morbidity of BS in low-risk patients is remarkably low and the mortality is zero. However, re-interventions increase with time after surgery and may not entirely depend on baseline patient factors or surgical performance (i.e.: abdominal pain of unknown origin or weight-loss induced cholelithiasis). This emphasizes the need for BS centers to show commitment to long-term follow-up of bariatric patients.
Objective: Impact of inguinal hernia defect size as stratified by the European Hernia Society (EHS) classification I to III on the rate of chronic postoperative inguinal pain (CPIP). BACKGROUND CPIP is the most important complication after inguinal hernia repair. The impact of hernia defect size according to the EHS classification on CPIP is unknown. Methods: In total, 57,999 male patients from the Herniamed registry undergoing primary unilateral inguinal hernia repair including a 1-year follow-up were selected between September 1, 2009 and November 30, 2016 . Using multivariable analysis, the impact of EHS inguinal hernia classification (EHS I vs EHS II vs EHS III and/or scrotal) on developing CPIP was investigated. Results: Multivariable analysis revealed for smaller inguinal hernias a significant higher rate of pain at rest [EHS I vs EHS II: odds ratio, OR = 1.350 (1.180-1.543), P < 0.001; EHS I vs EHS III and/or scrotal: OR = 1.839 (1.504-2.249), P < 0.001; EHS II vs EHS III and/or scrotal: OR = 1.363 (1.125-1.650), P = 0.002], pain on exertion [EHS I vs EHS II: OR = 1.342 (1.223-1.473), P < 0.001; EHS I vs EHS III and/or scrotal: OR = 2.002 (1.727-2.321), P < 0.001; EHS II vs EHS III and/or scrotal: OR = 1.492 (1.296; 1.717), P < 0.001], and pain requiring treatment [EHS I vs EHS II: OR = 1.594 (1.357-1.874), P < 0.001; EHS I vs EHS III and/or scrotal: OR = 2.254 (1.774-2.865), P < 0.001; EHS II vs EHS III and/or scrotal: OR = 1.414 (1.121-1.783), P = 0.003] at 1-year follow-up. Younger patients (< 55 y) revealed higher rates of pain at rest, pain on exertion, and pain requiring treatment (each P < 0.001) with a significantly trend toward higher rates of pain in smaller hernias. Conclusion: Smaller inguinal hernias have been identified as an independent patient-related risk factor for developing CPIP.
Basic research
Combination of neonatal porcine islets with mesenchymal stem cells of human and porcine origin improves islet function C. Gonelle-Gispert 1 , A. Balaphas 2 , J. Meyer 2 , E. Montanari 2 , L. Szabo 3 , S. Gerber 3 , L. Bühler 2 1 Surgical Research Unit, Faculty of Medecine, University of Generva, Geneva, Switzerland, Geneva University Hospitals, Geneva, Switzerland, 3 Institute of Chemical Sciences & Engineering, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland Objective: Neonatal porcine islets (NPIs) represent an unlimited source for islet xenotransplantation in type 1 Diabetes patients, despite limited function of neonatal tissue. We analyzed human bone marrow mesenchymal stem cells (hMSC) and pig exocrine tissue-derived MSC (pMSC) for their effects on islet function prior and after encapsulation. Methods: Pancreases were recovered from neonatal pigs and NPIs isolated by slicing, collagenase digestion and culture for maturation. Maturation of NPI was followed by Immunofluorescence studies and insulin secretion assay. pMSC were expanded and characterized by FACS. Insulin secretion assays of NPI co-cultured and co-encapsulated with MSC from human and pigs were performed to analyze their functionality. Results: Isolation of neonatal pancreases resulted in yields of 340'000 ± 160'000 IEQ (obtained from 3 pancreases in 5 experiments). Immunofluorescence staining of NPIs revealed increasing insulin + ◽-cells between day 9 and 21 in culture. Insulin content of NPI incrased progressively over time from 27.8 ± 11.47μg/l to 2466 ± 637.9 μg/l, at days 3 and 14, respectively, for 500 IE, p < 0.001). Culture and expansion of adherent cells from the pig exocrine tissue resulted in a homogenous CD90+, CD34-and CD45fibroblast-like population. Differentiation of these cells into adipocytes and chondrocytes showed their multipotentency. Secretion assays showed an increased insulin release from NPIs only when these were in cell-cell contact with MSC (for hMSC fold increase: 1.97 ± 0.27, for pMSC fold increase : 4.04 ± 1.1, p < 0.001) whereas without direct contact, insulin stimulation was not increased. Secretion assays performed on NPIs co-encapsulated with hMSC or pMSC in Ca2+-alginate microspheres after 3 days of encapsulation showed enhanced insulin secretion compared to NPIs encapsulated alone. Conclusion: MSC of human and porcine origin significantly enhance insulin secretion of NPIs when co-cultured in direct contact. Encapsulation of NPIs with MSC should be considered for clinical application. larger than those induced by VP (V = 11,7+-0,77 μm; VP = 8,9+-0,72 μm; control = 5,6+-0,34 μm; p < 0.05 V vs VP), confirming the ability of PDGF-BB to prevent aberrant vascular enlargement by high-dose VEGF. After 28 days fibrin was no longer detectable in any condition. Vessels induced by VEGF alone showed partial regression compared to 7 days (VLD V = 19,1+-1,5 mm/mm 2 ), which was prevented by addition of PDGF-BB (VP = 23,6+-1,1 mm/mm 2 ). Definitively remodeled vessels showed similar capillary-size diameters in all conditions by 28 days (V = 4+-0,15 μm; VP = 3,9+-0,12 μm; control = 4,2+-0,12 μm; p n.s.), suggesting a preferential regression of the more aberrant structures induced by high-dose VEGF alone. Conclusion: These results establish the feasibility of fibrin-based delivery of angiogenic factors in the skin of diabetic mice. Co-delivery of PDGF-BB both prevented aberrant angiogenesis and ensured persistence of new vessels despite transient factor delivery. Although spontaneous angiogenesis is impaired in diabetic mice, high-dose delivery of fibrin-bound VEGF and PDGF-BB was effective to induce robust growth of stable and physiological vascular networks. Objective: Rerouting portal vein flow induces slow liver regeneration. Associating Liver Partition and portal vein ligation for staged hepatectomy(ALPPS) induces rapid regeneration by adding parenchymal transection to portal vein ligation(PVL). In ALPPS but not PVL, hypoxia inducible factor-1α (HIF-1α) is upregulated in the liver and prolyl-hydroxylase inhibitors (PHI) also upregulate HIF-1α and accelerate liver regeneration. This study aims to clarify the role of HIF-1α in accelerating liver regeneration. Methods: Rat models of PVL, ALPPS, PVL+PHI (Dimethyloxaloylglycin )and intraperitoneal injection of the PHI in normal livers without portal vein rerouting, were compared. Liver volume was evaluated by CT scan. Proliferation of hepatocytes (HC) was evaluated by Ki-67 and DAPI staining. Liver sinusoidal endothelial cell (LSEC) density was evaluated by von Willebrand Factor(vWF) staining and hepatic stellate cell (HSC) activation by desmin staining. In vitro, HEP3B-cells(HC), LX2-cells(HSCs) and TRP3-cells(LSECs) were cultured under hypoxic conditions and under treatment with PHI. Proliferation was measured over 72h with the iCELLigence cell culture system via impedance. Conditioned media experiments were performed using media from HCs, HSCs and LSECs exposed to PHI for 24h and transferred to the other cell lines. Concentration of vascular endothelial growth factor(VEGF) was measured in hypoxic HSCs and blocked. Transcriptome analysis was performed using RNA extracts from hypoxia/PHI treated HSCs and media conditioned LSECs. Results: PPVL induces slow liver regeneration, while ALPPS and PVL treated with PHI accelerates volume increase and KI-67 proliferation by a factor of 1.8 and 3 respectively. While PHI without portal rerouting has no impact on volume, it leads to increased vascular density by vWF staining, also observed in ALPPS and PVL+DMOG. HSC activation is present in all rapid regeneration models and also the PHI treated normal livers without proliferation. In culture, PHI has an anti-proliferative effect on HCs, HSC and LSEC. However, transfer of media of PHI-treated HSC induces VEGF dependent proliferation of LSEC. Transcriptome analysis shows dominant expression of angiogenesis and matrix remodeling pathways. Conclusion: In conclusion, hypoxia signaling by HSCs induces VEGF-dependent angiogenesis and leads to rapid liver regeneration in ALPPS.
Hypoxia sensing of hepatic stellate cells leads to VEGF-dependent angiogenesis to accelerate liver regeneration in ALPPS
75.4 ± 6.6 pg/ml after incubation with 16 million platelets versus 2 ± 1.1 pg/ml without platelets). The same effect was observed using activated platelets or releasate of activated platelets. Strikingly, IL-6 secretion was highest when high molecular weight fractions (> 80 kDa) of platelet releasate obtained by size exclusion chromatography were tested (IL-6 maximal: 1343 ± 245.8 pg/ml versus control 8 ± 0.2 pg/ml, p < 0.05). LSEC exposed to platelets did not increase proliferation of primary hepatocytes but stimulated HGF secretion by HSC (HGF: 574.1 ± 124.5 pg/ml after stimulation versus 397 ± 72.5 pg/ml without stimulation, p < 0.05). Following partial hepatectomy, adhesion of platelets to LSEC was significantly increased (55.2 ± 2.1% adherent platelets after partial hepatectomy versus 29.6 ± 1.6% after sham surgery, p < 0.05). Conclusion: Our in vitro observations indicate that activated platelets release a component(s) of proteic nature inducing IL-6 secretion by LSEC, which in turn enhances release by HSC of HGF, the strongest mitogen for hepatocytes. Our in vivo data confirm that platelets adhere to LSEC shortly after liver injury.
International multicentre cohort study for the external validation of CLASSIC -Classification of Intraoperative Complications
Methods: In 18 centres from 12 countries, patients undergoing any type of surgery were consecutively enrolled, excluding one-day surgeries (NCT03009929). The attending surgical and anaesthesia team graded all intraoperative complications according to CLASSIC. All postoperative complications were assessed daily until hospital discharge and graded using the Clavien-Dindo classification. The association between the most severe intra-and postoperative complication (primary endpoint) was investigated using Spearman's rho. The association between the most severe intraoperative complication and the postoperative length of stay (pLOS; secondary endpoint) was investigated in a multivariable median regression model with robust standard errors considering study centre clustering. This analysis was adjusted for age, ASA-class, wound classification, complexity and urgency of the procedure. In a survey including 10 fictitious case scenarios describing intraoperative complications, reliability of CLASSIC was assessed using the intra-class correlation coefficient (ICC). Results: Out of 2640 patients screened, 2520 patients were enrolled, of which 610 (24%) experienced any intraoperative complication. 2508 postoperative complications were observed in 838 patients (33%). In-hospital mortality was 1% (n = 25). The Spearman correlation between the most severe intra-and postoperative complication was 0.22 (p < 0.001). In multivariable analysis, median pLOS increased with each CLASSIC grade (from 0.5 days (95% CI -0.03, 1.03) for Grade I vs 0, up to 4.5 days (95% CI 0.50, 8.50) for Grade IV vs 0). The survey (response rate 80%) showed an ICC of 0.75 (95% CI 0.59, 0.91). Practicability of CLASSIC was rated as 6 (IQR 5-7) out of 9. Conclusion: CLASSIC provides a validated and standardised tool to quantify and qualify intraoperative complications in clinical practice and research with a high reliability and practicability. Intraoperative complications show an association with important postoperative outcomes, rendering CLASSIC a useful tool to enhance perioperative patient safety.
Objective: High tibial osteotomy (HTO) is a joint preserving surgery in patients with varus knee alignment and knee osteoarthritis. The goal of HTO is achieving a balanced transfer of ambulatory load between the medial and lateral compartments of the knee. We investigated load-induced changes in biomarkers of articular cartilage metabolism before and after opening wedge HTO in patients with medial compartment knee osteoarthritis. Methods: Blood samples of ten patients (6 male; 44.3 ± 8.6 years, 25.8 ± 3.9 kg/m 2 ) were collected 4 weeks before and 6 months after HTO, each time immediately before (t0) and 0, 0.5, 1.5, 3.5, and 5.5 hours (t1-t5) after a 30-minute walking exercise on an instrumented treadmill. Serum levels of cartilage oligomeric matrix protein (COMP), matrix metalloproteinase (MMP)-3, -1, 9, interleukin-(IL)-6, C-propeptide II (CPII), cleavage of type II collagenases (C2C), Proteoglycan 4 (PRG-4) und A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS-4) were analyzed using commercial ELISA kits. Differences in serum levels were detected using ANOVA for repeated measures with surgery (pre/post) and time after 30-minute walking as within subject factors (P < 0.05). Results: Baseline COMP values were higher and C2C and CPII values were lower after the HTO (P < 0.05). Both pre-and postoperatively, COMP, MMP-3, C2C, and CPII increased by 10 to 70% immediately after the walking exercise, and PRG-4 decreased by 43% (P < 0.05). Up to 5.5 hours after the walking exercise, COMP and MMP-3 decreased to up to 25% below the baseline levels. IL-6 decreased 3.5 and 5.5 hours after the walking stress test by more than 400 and 500%, respectively. Both pre-and postoperatively, PRG-4 and MMP-9 showed clear maxima 3.5 hours after the walking exercise. Conclusion: The immediate and delayed load-induced changes in biomarkers of articular cartilage not only suggest diffusion of biomarkers but also (possibly delayed) metabolic processes, respectively. The decrease in PRG-4 -or lubricin -immediately after the walking exercise may indicate increased friction of the arthritic joint. The lacking pre-to postoperative differences in load-induced changes in cartilage biomarkers may be caused by individually different load corrections of the HTO, which may result in individually different magnitude of load-induced changes. We will evaluate these possibilities in subsequent analyses.
Hand

Shorter rehabilitation after extensor pollicis longus reconstruction combining side-to-side tendon attachment and new active rehabilitation protocol
T. Cordier, S. Schibli
Department of Hand Surgery, Cantonal Hospital Graubünden, Chur, Switzerland
Objective: Rupture of the Extensor pollicis longus tendon (EPL) is frequently associated with distal radius fractures. For EPL reconstruction the Extensor indicis tendon (EI) is transferred to the distal end of the EPL. Common suture techniques combined with established rehabilitation protocols have proven to achieve good results. However, patients regularly experience restrictions of hand function for three months. In addition, current rehabilitation protocols tend to be complex and depend on substantial support from hand therapists.
Compared to the Pulvertaft technique, the Side-to-Side (STS) suture technique provides improved strength and has been successfully implemented for tendon transfers.
In this prospective study we analysed, wether combining a Side-to-Side suture technique with a straightforward active rehabilitation protocol based on the increased suture stability simplifies and shortens time of rehabilitation after EPL reconstruction. Methods: Between 11/2015 and 04/2017 we treated a series of 10 patients, median age 56 (range 18-70) after closed EPL-rupture using STS suture technique for EI to EPL transfer. For postoperative rehabilitation we implemented a simplified Controlled-Active-Motion protocol. Clinical follow up was at 2, 4 and 8 weeks postoperatively and additionally one year later by phone. Primary endpoints were the unrestricted use of the operated hand or major complications, defined as tendon rupture or relevant tendon elongation. We reported on patient satisfaction and pain. As objective parameter active range of motion of the thumb and index finger as well as pinch and grip strength were measured. Results: All 10 patients underwent surgery and postoperative rehabilitation without complication. All 10 were satisfied with the treatment 8 weeks and one year postoperatively. All were back to work after 8 weeks or could use the operated hand without any restriction. At 8 weeks all patients achieved a powerful active extension of the IP-joint of the thumb. Pinch-and grip-strength reached on average 83% and 81% of the contralateral side. Conclusion: Despite the small group and the relative short follow up the results suggest that the Side-to-side suture technique in combination with an adapted active rehabilitation protocol provides a safe and successful method for EPL reconstruction. Compared with the current literature this concept shortens time of rehabilitation by a third. Hepatobiliary and Pancreatic Surgery, Carolinas Medical Center, Charlotte, USA, 3 Pancreatic Surgery Section, Humanitas Cancer Center, Milan, Italy, 4 Department of Digestive Surgery, Edouard Herriot Hospital, Lyon, France, 5 Department of Visceral Surgery, Hamburg, Germany Objective: Incomplete resection (R1) after pancreatoduodenectomy and lymph node (LN) invasion have been described as factors of poor prognosis in patients with pancreatic ductal adenocarcinoma (PDAC). It is nevertheless unclear if R0 resection after pancreatoduodenectomy compared to R1 resection has a real positive impact on survival and recurrence in patients with LN invasion. This study aimed to compare overall survival (OS) and recurrence rate between R0 and R1 resections among PDAC patients with LN invasion. Methods: A retrospective international multicentric study was performed including 5 tertiary centers (1 in the USA and 4 in Europe). Patients with PDAC without neoadjuvant treatment were included. R1 resection was defined as positive histological margins. Survival was measured from operation date to last follow-up date or death. Median OS was calculated using Kaplan-Meier curves and compared using log-rank tests. Multivariable Cox regression analysis was performed to find negative predictive factors for OS. Results: From the 5 participating centers, 990 patients with pancreatoduodenectomy for PDAC were included. A total of 789 patients had LN invasion (80%) and 201 had no LN invasion (20%). Perioperative mortality was 3% (30/990) and overall morbidity 60% (593/990). For the entire cohort, median OS was 24 months (95% CI: 22-26). Median OS was longer for patients without LN invasion compared to patients with LN invasion (45 vs. 21 months, p < 0.001). Recurrence after R0 resection was also lower in patients without LN invasion (26%) compared to patients with LN invasion (52%, p < 0.001). 
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Among patients with LN invasion, median OS was similar between patients with R0 and R1 resection (25 vs. 22 months, p = 0.646). Recurrence rates were also similar between R0 and R1 resections (209/391 = 53% vs. 195/355 = 55%, p = 0.686). On multivariable analysis R1 resection was not an independent factor of worse OS (HR: 0.9, 95% CI: 0.8-1.2, p = 0.958). Only tumor size was associated with poor OS (HR: 1.1, 95% CI: 1-1.1, p = 0.045).
Conclusion:
In PDAC patients with pathological positive LN invasion, resection status had no influence on OS and recurrence rates. Extensive surgery to achieve R0 resection in such patients might not influence the course of the disease. Objective: The combination of the simultaneous occlusion of the portal veins supplying and the hepatic veins draining the liver (DVO) has been shown to induce rapid hypertrophy of the future liver remnant (FLR) in animal studies and pilot human studies. This study compares two different methods of DVO in two different centers. Methods: The records of patients undergoing embolization of both portal and hepatic veins in a Swiss and Spanish center were reviewed. Demographics, indications and liver volume were analyzed by standardized liver remnant volume (sFLR), liver to body mass ratio (LBWR) and clinical outcomes were assessed. Technical difference between the two centers were compared. The primary interest was feasibility of resection. Results: Between 09/2017-11/2018, the Swiss and the Spanish center performed DVO in 5 and 8 patients, respectively. The Spanish center performed portal vein ligation in a first stage and then hepatic vein embolization by interventional radiology (IR) after an average of 8.9 days, the Swiss center performed simultaneous portal and hepatic vein embolization by IR. Diagnosis was bi-lobar colorectal liver metastasis (CRLM) in 12 patients, and intrahepatic cholangiocarcinoma (IHCC) in one patient. 12/13 patients underwent resection (feasibility 92%). Median age was 54 (IQR 50 -66) years. sFLR and LBWR were 0.26% and 0.58, respectively, prior to DVO, 0.40% and 0.88 at a median of 20 days afterwards. The kinetic growth rates between the Swiss and the Spanish cohort were comparable (0.13% sFLR/week vs. 0.05% sFLR/week, p = 0.14). Conclusion: Occlusion of portal and hepatic veins can be achieved using different methods to gain comparable volume growth in this small series. This novel technique has to be studied further prospectively and compared to the gold standard of portal vein embolization. Objective: Hypoxia occurs in solid tumors and leads to increased invasiveness due to epithelial-mesenchymal transformation, activation of the Warburg effect and decreased anti-tumor immunological responses. The novel anti-hypoxic molecule myo-inositoltrispyrophosphate (ITPP, OXY111A) acts as an allosteric effector of hemoglobin and counteracts counteracts hypoxia-induced tumor aggressiveness showing decreased tumor burden and increased survival in five different animal solid tumor models both applied as monotherapy and increased beneficial effects when followed by standard chemotherapy. Methods: The present study is a first in-human exploratory, prospective, open-labelled, mono-centric Phase IB study according to a classical 3+3 dose escalation design (ClinicalTrials.gov Identifier: NCT02528526) in patients with non-resectable primary and secondary tumors of the liver, pancreas, and biliary tract. The study intervention consists of 9 infusions of ITPP over 3 weeks, followed by administration of conventional cytotoxic chemotherapy. Primary endpoint is the determination of safety and tolerability of ITPP, secondary endpoint is assessment of efficacy/tumor response with FDG-PET/CT and MRI. Results: 30 patients were included between 04/2015 and 12/2017, with 1 patient withdrawn from the study and 22 assessed for the primary endpoint. ITPP administration was safe, well tolerated and no dose-limiting toxicity was encountered up to the maximal dose currently tested (Cohort 7: 12'390mg/m 2 ). 6 serious adverse events were recorded, none of it related to ITPP. 30 adverse events occurred, with 15 of those judged to be possibly or definitively related to ITPP, with 11 patients experiencing hypercalcemia, 2 hyponatremia, 1 hypomagnesemia and 1 hypokalemia (all CTCAE Grade 1). 8 patients had radiological disease stabilization under ITPP treatment with 3 patients experiencing a decrease in tumor markers. 4 patients had stable disease under consequent chemotherapy, while 5 benefited of a strong partial response. Conclusion: Administration of ITPP before chemotherapy is safe and well tolerated with neglible side-effects. Further exploration of its anti-tumor efficacy in Phase II/III trials is highly warranted.
Initial experience of "Double" portal and hepatic vein occlusion to induce rapid liver hypertrophy -comparison of two different techniques
ITPP -a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato -biliary neoplasms -results of a phase IB clinical trial
Natural Orifice Transluminal Endoscopic Surgery (NOTES): nine years' experience with 571 hybrid transvaginal cholecystectomies
F. Rössler, U. Bieri, A. Keerl, A. Nocito
Department of Surgery, Cantonal Hospital Baden, Baden, Switzerland
Objective: To assess outcome and safety of 571 hybrid NOTES cholecystectomies, representing the largest single-center cohort.
Methods:
We retrospectively analyzed all consecutive NOTES cholecystectomies performed in our center between June 2009 and January 2018. All procedures were performed using a hybrid transvaginal technique, including an additional umbilical small-size trocar. Endpoints, calculated at discharge, 30 and up to 90 days postoperatively, included intra-and postoperative morbidity assessed by the validated Clavien-Dindo Classification and the Comprehensive Complication Index (CCI). Special focus was held on pre-and postoperative gynecological conditions and whether or not preoperative gynecological examination is necessary in all patients.
Results:
We performed 571 hybrid NOTES cholecystectomies within nine years. The vast majority were elective, 9.6% emergency cholecystectomies. Mean operation time was 64 ( ± 25) minutes and mean hospital stay 2.56 ( ± 3.3) days, (range 1 to 54 days). 6.7% of patients developed at least one complication until discharge, most of them minor (≤Grade II), mainly due to urinary infections or retention. 30-and 90-day complication rates were 10.7% and 11%, respectively. Mean CCI at discharge, postoperative day 30 and 90 was 1.45 ( ± 6.4), 2.3 ( ± 7.7) and 2.4 ( ± 7.8) respectively, ranging from 0 to 60. Objective: Resection margin status is associated with oncologic outcomes following liver resection for colorectal liver metastases (CLM). Previous studies however, did not differentiate between true local recurrence at the resection margin versus recurrence elsewhere in the liver. This study aims to determine if resection margin represents only a surrogate of advanced disease while not causally determining overall survival (OS). Methods: Clinicopathological data of patients who underwent curative hepatic resection for CLM between 2012 and 2017 at a major hepatobiliary center in Switzerland were assessed. Follow-up cross-sectional imaging following hepatectomy was reviewed by an independent radiologist to identify the presence and location of recurrent disease. Location of intrahepatic recurrence was distinguished in true local recurrence (only at the resection margin) versus intrahepatic recurrence elsewhere. The association between surgical margin status and location and frequency of tumor recurrence was evaluated and the impact of true local recurrence on OS was analyzed.
Results: During the study period, 91 patients underwent liver resection for CLM with curative intent. Surgical margins were positive for tumor cells (R1) in 10 patients (11%). After a median follow-up time of 47 months, tumor recurrence was identified in 54 patients (59%). Location of recurrence disease was independent from the R1 status (p = 0.063). True local recurrence was not associated with worse OS among patients with recurrent disease (true local recurrence vs. elsewhere: 3-year OS: 73% vs. 65%, p = 0.729).
Main determinants of survival were no recurrence, any intrahepatic recurrence, and extrahepatic recurrence (p = 0.012). Conclusion: R1 margin status was not associated with more frequent true local recurrence compared to other locations of recurrent disease. Additionally, the impact of true local recurrence on OS was not significantly different from that of any intrahepatic recurrent disease. Thus, based on our findings, R1 status should be considered as a surrogate parameter of extensive disease and potentially aggressive tumor biology. It should be used as an indicator for the need of intensive systemic treatment and close postoperative surveillance.
Objective: Patients with rectal cancer and complete response to chemoradiotherapy (CRT) can be treated with the aim of organ preservation by applying a watch and wait strategy. However, if secondary radical surgery is needed due to cancer recurrence, this may be associated with an increased complication rate or even worse prognosis. Therefore, restaging after CRT is of paramount importance to decide whether organ preservation protocols can be applied. This study aims to assess the accuracy of radiological restaging after CRT in a cohort of patients undergoing neoadjuvant treatment followed by oncological rectal resection for cancer. Methods: Patients undergoing surgery for rectal cancer after CRT at our institution prior to the implementation of an organ preservation program were analyzed retrospectively. For all patients radiological T and N restaging by MRI after CRT but prior to surgery was compared to final pathological T and N staging. The rates of over-and understaging and sensitivity for radiological prediction of complete response were calculated. Results: 64 patients (mean age 65 years, 72% male) undergoing treatment for rectal cancer between 2013 and 2017 were analyzed. Radiological T stage after CRT was underestimated in 17% (11/64), correct in 45% (29/64) and overestimated in 38% (24/64) of patients. Radiological N stage was underestimated in 17% (11/64), correct in 58% (37/64) and overestimated in 25% (16/64) of patients. Five patients out of 65 patients (7.7%) showed pathological complete response after CRT. Radiologically, complete response was described in only one of these five patients (sensitivity for complete response 20%). In none of the patients complete response was described by mistake. Conclusion: Radiological assessment after CRT resulted in the correct tumor and nodal stage in about half of the examined patients. Overestimation of T and N stage was more frequent than underestimation, this is most probably due to remaining scar tissue after CRT. No patient was incorrectly staged as T0 or N0. Pathological complete response could be predicted correctly in only one of five patients. Therefore, clinical staging by digital rectal examination and endoscopy remains very important in the evaluation of rectal cancer after CRT. Further, histological or molecular markers are needed to better predict response to CRT and to identify patients that qualify for organ preservation.
The pancreatic cancer cohort included 1 patient with early intra-ductal carcinoma, 1 patient with stage II, 1 patient with stage IV and 2 patients with stage III disease. The colorectal cancer group consisted of 1 patient with stage I, 3 patients with stage II and 2 patients with stage III disease. 29 participants did not have a cancer diagnosis. The predictive machine learning algorithm performed at an overall accuracy of 0.9583, with a specificity of 1 and a sensitivity of 0,74. After unmasking the clinical diagnoses, machine learning showed 100% accuracy in distinguishing cancer patterns from controls. Conclusion: Despite a very limited learning set, this new approach combining custom DNA extraction, ONGS and machine learning appears to deliver a clinically relevant accuracy for detecting colorectal and pancreatic cancer. As such, it might be a useful tool for early cancer detection for diagnosis, assessing treatment response including a liquid post-operative pathology, and monitoring disease recurrence through blood samples. However, more clinical data is needed to further determine the precise role of this approach. Objective: Safety and short-term efficacy of perianal block as sole anesthesia in proctologic interventions have been demonstrated before. However, in Switzerland, perianal block is more frequently used as an adjunct to general or regional anesthesia for postoperative pain control. This study aims to evaluate the influence of adjunct perianal block for prolonged pain control after proctologic surgery. Methods: 138 patients undergoing surgery for hemorrhoids, anal fistula or anal fissures were randomized in two equal groups. The intervention group received 40 milliliters of 0.5% ropivacaine solution injected in each perianal quadrant. The control group received perianal injection of 40 milliliters of 0.9% NaCl solution. Patients, surgeons and assessors were blinded for the group allocation. Pain was assessed using a numeric rating scale (NRS; 0 = no pain, 10 = strongest pain) at 1, 2, 3, 12, and 24 hours after surgery. The need for opiates was monitored in the first 24 hours and calculated in intravenous morphine equivalents. Primary outcome was pain 24 hours after surgery. Results: Patients were allocated to perianal ropivacaine or placebo as an adjunct to general (n = 41 and 43) or spinal anesthesia (28 and 26; p = 0.86) between february and december 2018. Within the groups surgery for hemorrhoids (42 and 40), fistulas (22 and 24), and fissures (5 each) were equally distributed (p = 0.93). Mean NRS was lower in patients that received perianal block with ropivacaine (1.2 ± 0.2) compared to placebo (1.8 ± 0.3; p = 0.042) 24 hours after surgery. Lower NRS were also found 1 hour (1.1 ± 0.2 and 2.0 ± 0.3; p = 0.01), 2 hours (0.8 ± 0.2 and 1.3 ± 0.2; p = 0.03), 3 hours (0.8 ± 0.18 and 1.3 ± 0.2; p = 0.04), and 12 hours (0.9 ± 0.2 and 1.6 ± 0.2; p = 0.01) after surgery in the intervention group compared to placebo. The need for opiates was reduced in the ropivacaine (3.1 ± 0.6 mg) versus the placebo group (5.0 ± 0.7mg, p = 0.04). Conclusion: Perianal block as an adjunct to general or spinal anesthesia in proctology reduces postoperative pain and analgesia requirements even beyond the duration of action of ropivacaine. Considering the ongoing trend towards ambulatory surgery perianal block may gain even more attraction.
Fascin -1 expression in colorectal cancer: is there a high risk group of patients prone to metastasis already in early stage disease? Objective: Fascin is a stem cell marker that regulates adhesion dynamics and stabilizes cell protrusion such as filopodia. In human cancer, fascin expression has been correlated with malignant tumors exhibiting aggressive clinical features. The aim of the present study was to assess the expression patterns of fascin in colorectal cancer and to determine its prognostic significance. Methods: A validated assay comprised of 111 specimens of patients with primary resectable colorectal cancer, were assessed via immunohistochemistry for the expression of fascin-1. Cut-off points to define levels of expression of fascin-1 were determined by using Roc-curve and X-tile. Results were correlated with clinicopathological characteristics and survival data.
Results: Fascin-1 was strongly expressed in the cytoplasm of the colorectal cancer cells and in endothelial cells of tumor blood vessels. High fascin-1 expression was associated with progressive T stage (p = 0.007), the presence of lymph nodes (p < 0.001) and distant metastasis (p = 0.002), low grade differentiation (p = 0.002), vascular invasion (p < 0.001). Patients exhibiting high expression of fascin-1 demonstrated a significantly worse 3-year progression free survival (20% vs 75%, p < 0.001) and 5-year overall survival (13.3% vs 80%, p < 0.001). Subgroup analysis comprised of patients with UICC stage I and II only, demonstrated as well a significantly worse 5-year overall survival (48% vs 93.5%, p = 0.007) when fascin-1 expression exists. High fascin-1 expression was confirmed in the multivariate analysis using Cox proportional hazard models as an independent prognostic factor of worse progression free survival (HR; 0.290, 95% CI = 0.118-0.714) and poor overall survival (HR; 0.256, 95% CI = 0.082-0.800).
Conclusion:
High fascin-1 expression in colorectal cancer is an independent negative prognostic factor for progression free and overall survival. Fascin-1 could possibly represent a target for immunotherapy or could be utilized to identify patients at high risk to develop disease recurrence and/or metastasis already in early stage disease.
High risk of underlying neoplasia in complicated appendicitis
A. Litchinko, A. Miftaroski, B. Egger
Department of Surgery, HFR Fribourg -Cantonal Hospital, Fribourg, Switzerland
Objective: Appendectomy is one of the most frequent routine operation performed nowadays. At histological examination of the resected specimens, neoplasia of the appendix is found in 1-2%. Recent studies have demonstrated that the risk of neoplasia in patients with complicated appendicitis, abscess formation and > 40 years of age is up to 29%.
Methods:
We present here a retrospective study of data out of a prospective database with 20 adult patient undergoing interval appendectomies after drainage for complicated appendicitis with abscess formation during a 11-year period at a single regional hospital. In a previous study, published in 2017, we presented a cohort of 15 patients with complicated appendicitis and abscess formation undergoing a two-step procedure with initial drainage and then interval appendectomy. In this study we already underlined the high risk of an underlying malignant neoplasia in this population. In the present study, 5 more patients have been added to our already published cohort and data evaluated again. Results: 20 patients were treated for complicated appendicitis with drainage and undergoing then interval appendectomy. Among them, 2 patients (10%) were diagnosed with malignant neoplasia. Considering only patients > 40 years of age, this value rises up to 15%. Conclusion: In summary, our results are consistent with recent findings in the literature. Despite the persistent controversy what concerns the treatment of complicated appendicitis, this study strongly suggest that interval appendectomy should be performed shortly after conservative management (drainage) due to the high risk of a possible underlying malignant neoplasia; especially in patients > 40 years of age.
Objective: T cell infiltration has been recognized to significantly impact clinical outcome in human colorectal cancer (CRC). Interleukin 22 (IL-22), a cytokine secreted by IL-17-producing CD4+ T cells (Th17) is known to play a crucial role in inflammatory bowel disease and has been shown to have protumorigenic activity in mouse tumor models. However, its role in human CRC is still unclear. As consequence, we evaluated the prognostic and functional impact of IL-22 producing cells in human CRC in this follow-up study. Methods: In order to evaluate IL-22 expression in CRC, immunohistochemistry was performed on a well-characterized TMA including 425 cases of Primary CRC. Moreover, phenotypic characterization of IL-22 positive cells was assessed by flow cytometry of single cell suspensions. Next, in vitro experiments were done to further elucidate the effects of IL-22 on CRC cells. Results: IL-22 positive cells were detected both within tumor cells and tumor infiltrating immune cells. Whereas, IL-22 expression by tumor cells did not affect prognosis, densities of IL-22 positive immune cells were found to be significantly associated with early T stage and MMR-deficient microsatellite stability. Importantly, IL-22 expression by CRC infiltrating immune cells was predictive of improved overall survival independent of known prognostic factors such as T stage, N stage, tumor grade, vascular invasion, tumor border configuration and MMR status. Phenotypic characterization of IL-22 positive cells revealed that they consist mainly of polyfunctional CD4+ and CD8+ T cells, also producing IL-17 and IFN-g. Moreover, in vitro experiments showed a new role of IL-22 in stimulating CRC cells to release chemokines promoting neutrophils recruitment.
Conclusion:
In conclusion, our data suggest that by stimulating production of neutrophil recruiting chemokines in tumor cells, IL-22-producing T cells might favor CRC infiltration by neutrophils, thus contributing to a more favorable clinical outcome. Objective: The aim of this study is to compare the incidence of incisional hernias and wound infections in patients that underwent an elective laparoscopic resection for recurrent sigmoid diverticulitis with specimen extraction through a left lower transverse incision or a Pfannenstiel-Kerr incision. Methods: Two hundred sixty-nine patients underwent elective laparoscopic sigmoidectomy between January 2014 and December 2017. Of those patients with specimen extraction through a left lower transverse incision (LLT) and patients with specimen extraction through a Pfannenstiel-K incision (P-K) were matched 1:1 controlling for age, sex, comorbidities, and previous abdominal surgery. The baseline data and the results were compared using Fisher's exact test. Minimum follow-up was 12 months. Results: After matching, 77 patients in the LLT group and 77 patients in the P-K group were found to be equivalent regarding above mentioned clinical-demographic characteristics. No patients in the P-K group developped an incisional hernia compared to 10 patients (13%) in LLT group (p = 0.0014). All of these patients needed hernia repair with a mesh implantation. In the P-K group the wound was protected using an Alexis ® wound protector in 65%, V-drape ® in 14%, or not protected in 21%. In the LLT group the wound was protected using an Alexis ® wound protector in 14%, V-drape ® in 22%, or not protected in 64%. The rate of wound infections was 1/77 in the P-K group and 0/77 in the LLT group (p = 1.0).
Is there a relation between adequate nurse staff and the incidence of infectious complications in patients undergoing colorectal surgery within an ERAS program?
Conclusion:
The Pfannestiel-Kerr incision may be the preferred extraction site compared to the left lower transverse incision given the significant reduction of the risk of incisional hernias. No difference was shown in the incidence of wound infections, regardless of the use of an intraoperative wound protector. Objective: This retrospective observational study analyses the outcomes of patients who underwent surgery for anal fistula at a single center. Methods: During a time period of 9 years (01/2005-05/2013) all patients with anal fistula were included. Baseline characteristics, details of presentation, fistula anatomy, type of surgery, post-surgical outcomes and follow-up data were collected. Exclusion criteria were chronic inflammatory bowel disease and previous operation of anal or rectal cancer. The primary endpoints were long-term closure rate and recurrence rate (RR) after 2 years. Secondary endpoints were persistent pain after 2 years, postoperative complications and continence status. Results: A total of 65 patients (52 males, 13 females) with a mean age of 49.7 years were included. The total amount of analyzed operations was 93 which were performed in 78 fistulae. Seventy percent of the performed operations were fistulotomies (n = 65), 14% mucosal advancement flaps (n = 13), 8% anal fistula plugs (n = 7) and 8% cutting-setons (n = 8). The mean follow up was 80.5 months. Healing was achieved in 84% with a total RR of 16% (n = 15). The highest RR was seen in anal fistula plug with 57%. No recurrence was observed in the total of 8 cutting-seton procedures. For mucosal advancement flap the RR was 23% and for fistulotomy 12%. Detailed analyses of fistulotomy patients show different RR in high fistulae with 28%, comparing to low fistulae with a RR of 6%. Furthermore, 80% of the recurrent high fistulae were not previously treated with a seton. Postoperative infection with abscess but without progression into a recurrent fistula, was seen in 7 of the 65 fistulotomies (complication rate of 11%). For all the different procedures there was no persistent postoperative pain nor incontinence in the long-term follow up.
Longterm outcome of anal fistula -a retrospective study
Conclusion: Despite of all the new innovative and minimal invasive operations for the treatment of anal fistula, the healing rate does not show similar results when compared with traditional techniques. In addition, even though the use of cutting-seton is discussed as an outdated technique, the right use in respect of its limitations can be a helpful and easy operation with good results even for the feared complication of incontinence. Further trials are needed to elucidate the efficacy and potential benefit of each technique available in anal fistula treatment.
Long -term quality of life is similar in operated and conservatively managed patients with diverticular disease D. W. Stimpfle, E. Gerns, U. Zingg
Department of Surgery, Limmattal Hospital, Schlieren, Switzerland
Objective: There is substantial debate whether elective surgery in diverticular disease is indicated at any point. Sceptics argue, among other things, that morbidity is high and quality of life is impaired after surgery. The aim of this study was to analyse the long-term quality of life of operated patients with comparison to a conservatively managed cohort. In the operated group the number of attacks (p = 0.002) and the Hinchey score (p = 0.005) were significantly higher. Median of GIQLI Score was 123 in non-operative patients and 119 in operative patients, respectively (p = 0.308). Number of attacks, Hinchey score, and severity of diverticular disease in colonoscopy had no significant influence on the GIQLI score. Overall short-term surgical morbidity in the surgery group was 22.7%, with an anastomotic leak rate of 3.4%. Overall long term complications were significantly higher in the operated group [45 (37.8%) vs. 5 (16.1%), p = 0.023]. 11 patients (9.2%) in the operated group and 4 (12.9%) in the non-operated group had anamnestically recurrent attacks (p = 0.514). Impaired urinary and sexual function, respectively, occurred in 7 (5.9%) and 11 (9.2%) patients in the surgery group, none in the conservative group. 9 operated patients (7.6%) developed incisional hernia, 5 (4.2%) anastomotic stricture and 1 (0.8%) a small bowel obstruction. Conclusion: Despite relevant short and long term morbidity, patients undergoing resection for diverticular disease reach similar GIQLI quality of life scores compared to conservatively treated patients. However, the surgery must be indicated with care and awareness of a substantial morbidity in the long term.
Objective: Adequate perfusion is crucial for optimal anastomotic healing. Fluorescence-based enhanced reality (FLER) is used to quantify fluorescence signal dynamics and to superimpose a virtual perfusion cartogram onto real-time laparoscopic images. In current surgical practice, fluorescence-guided perfusion estimation is obtained from the serosal side. The aim of this experimental study was to quantify potential differences (due to a different ischemia response) in mucosal and serosal perfusion levels in an ischemic colon segment. Methods: An ischemic colon segment was created in 12 pigs. Simultaneous quantitative serosal and mucosal fluorescence imaging was obtained via intravenous indocyanine green injection (0.2mg/kg), using 2 near-infrared camera systems, and computer-assisted FLER analysis. Lactate levels were measured in capillary blood of the colonic wall at 7 regions of interest (ROIs) as determined by FLER analysis: the ischemic zone (I), the threshold of a 50% signal intensity variation over time proximally and distally at the mucosal and serosal side (P50M, P50S, D50M, D50S) and the proximal and distal vascularized areas (PV, DV). Results: Perfusion level differences between mucosa and serosa were clearly identified using the perfusion cartographies. The mean ischemic zone as measured (mm) at the mucosal side was significantly larger than the serosal one (56.3 ± 21.3 vs. 40.8 ± 14.9, p = 0.001), with a mean difference of 1.5 ± 1.2cm. Mean lactate levels (mmol/L) in the ischemic area (3.8 ± 2.1), were significantly higher than those in P50M (2.2 ± 2.7, p = 0.0007), P50S (2.6 ± 2.6, p = 0.01), D50M (2.4 ± 2, p = 0.002), D50S (2.8 ± 1.9, p = 0.003), and vascularized zones (PV 1.75 ± 2.2, p = 0.0001; DV 1.7 ± 2.2, p < 0.0001). Due to the symmetrical distribution of ischemia, the pooled analysis of proximal (n = 24) and distal (n = 24) lactate levels showed significantly higher levels at the serosal side (2.7 ± 2.2 vs. 2.3 ± 2.3, p = 0.02).
Conclusion:
In an experimental model of acute ischemia, the simultaneous image acquisition of both colonic wall sides showed larger ischemic mucosal zones as compared to serosal ones. The potential clinical relevance of these results calls for an assessment of perfusion from the mucosal side or for performing a larger resection when basing the analysis on serosal perfusion. Further studies are required to predict the optimal resection margin and anastomotic site in colonic resections. Objective: Analysis of tumor immune-infiltration has been suggested to outperform TNM staging in predicting clinical course of colorectal cancer (CRC). Infiltration by cells expressing OX40, a member of the TNF receptor family, or CD16, expressed by natural killer cells, monocytes and dendritic cells, has been associated with favorable prognosis in patients with CRC. We hypothesized that assessment of CRC infiltration by both OX40+ and CD16+ cells might result in enhanced prognostic significance. Methods: CRC infiltration by OX40 and CD16 expressing cells was investigated in 441 primary CRCs using tissue microarrays and specific antibodies, by immunohistochemistry. Patients' survival was evaluated by Kaplan-Meier and log-rank tests. Multivariate Cox regression analysis, hazard ratios and 95% confidence intervals were also used to evaluate prognostic significance of OX40+ and CD16+ cell infiltration.
Tumor infiltration by OX40+ cells enhances the prognostic significance of CD16+ cell infiltration in colorectal cancer
Results: CRC infiltration by OX40+ and CD16+ cells was subclassified in 4 groups with high or low infiltration levels in all possible combinations. High levels of infiltration by both OX40+ and CD16+ cells were associated with lower pT stage, absence of PTL inflammation and a positive prognostic impact. Patients bearing tumors with high infiltration by CD16+ and OX40+ cells were also characterized by significantly longer overall survival, as compared with the other groups. These results were confirmed by analyzing an independent validation cohort. Conclusion: Combined infiltration by OX40+ and CD16+ immune cells is an independent favorable prognostic marker in CRC. The prognostic value of CD16+ immune cell infiltration is significantly improved by the combined analysis with OX40+ cell infiltration. Objective: Drug resistance inevitably limits clinical efficacy of cancer treatment, which is particularly relevant for KRAS-mutant cancers, the most common type of human malignancies defined by genetic alterations and the largest subset of tumors that cannot be effectively targeted by currently available therapeutics. The purpose of this study is to identify novel drug targets whose inhibition enhances the antitumor efficacy of standard first-line chemotherapy. Methods: Various in vitro models that recapitulate KRAS-mutant lung cancer cells evolving acquired resistance to chemotherapy (cisplatin/pemetrexed) were generated and subjected to pharmacological screens. Tumor vulnerabilities selectively associated with drug-resistant cells were identified and characterized by in vitro, ex vivo and in vivo approaches.
Thorax
Results:
We found that the mammalian target of rapamycin (mTOR) pathway is hyperactivated in KRAS-mutant lung cancer cells that evolve resistance to chemotherapy and in patient-derived KRAS-mutant lung adenocarcinoma treated with chemotherapy. We further showed that drug-resistant KRAS-mutant lung cancer cells rely on persistent mTOR signaling for survival and that its inhibition restores sensitivity of resistant KRAS-mutant lung cancer cells to chemotherapy. Importantly, drug combinations of clinically approved mTOR inhibitors with chemotherapy synergize in inhibiting cell proliferation of KRAS-mutant cancer cells in vitro and in vivo. These results pinpoint activated mTOR signaling as a mechanism of resistance to chemotherapy in KRAS-mutant lung cancer and validate a rational and readily translatable strategy to treat KRAS-mutant lung cancer. Conclusion: Our study identifies a novel mechanism of resistance mechansim to chemotherapy and validates a combination strategy to treat KRAS-mutant lung cancer.
Methods:
The records of 158 chest wall reconstructions performed in 150 patients between 2003 and 2018 by a joint team of reconstructive and thoracic surgeons were reviewed. We determined, for each patient, the extent of resection, the reconstruction type, the postoperative surgical and non-surgical complications and the oncological long-term outcome. Results: Chest wall resections were performed in the context of lung cancer (31%), primary chest wall tumors (33%), breast cancer (15%) or metastasis (20%). Full thickness (skin, muscle, ribs ± sternum ± clavicule) chest wall resection was performed in 66 cases while the other 92 cases involved bony chest wall with no superficial soft tissue. Associated lung resections were required in 72 patients (wedge 43%, lobectomy 43%, pneumonectomy 14%). Chest wall reconstructions were performed using pedicled muscle flaps (15%) prosthetic chest wall subsitutes (mesh with and without methyl methacrylate reinforcement, 38%) or a combination of both (47%). The postoperative mortality was of 2.5% and related to septic/hemorrhagic shock (n = 3) and pulmonary embolism (n = 1). Postoperative morbidity consisted of pneumonia (21%), arrhythmia (10%), pleural effusion (15%) and pulmonary embolism (2%). A complete tumor resection was obtained in 123 patients (78%) and chest wall stability and integrity was achieved in all patients. Mean patient follow-up was of 44 ± 43 months Overall and disease free survival were 46 ± 44 and 31 ± 41months, respectively. Conclusion: Chest wall resections and reconstructions performed in the context of a multimodal approach can offer rewarding overall and disease free survivals while preserving the chest wall integrity and functionality. Postoperative morbidity and mortality rates are acceptable. Thoracic and Encodrine Surgery, Geneva University Hospitals, Geneva, Switzerland, 2 Division of Pneumology, Geneva University Hospitals, Switzerland Objective: Fibrinolysis can be used to improve fluid drainage in pleural infection. Treatment with either urokinase or tissue plasminogen activator (t-PA) in association with deoxyribonuclease (DNase) via a chest tube has been effective at reducing the need for surgery. This study is the first to compare the efficacy of these two treatments.
Comparison of intrapleural use of urokinase and t-PA/DNase in pleural infection
Methods:
We performed a single-centre controlled prospective cohort study. All individuals with pleural infection admitted to our hospital between January 2014 and December 2017, who were treated with antibiotics, a chest tube, and fibrinolysis, were included in this study. The rate of additional procedure requirements (additional chest tube or surgery) after initial fibrinolysis, complications, costs, and radiological and biological outcomes were analysed. Results: Among the 93 patients included in this study, 34% experienced additional procedure after an initial fibrinolysis, including 21% who received an additional chest tube and 13% who underwent thoracoscopy. The need for additional procedure arose due to presence of multiple pleural collections (P = 0.01) and was associated with the use of large-bore drain (P = 0.01). The success rate of fibrinolysis was not significantly different between urokinase and t-PA/DNase (P = 0.35). The difference in drainage duration and in length of hospital stay were not significant as well (P = 0.05 and P = 0.12, respectively). Treatment with t-PA/DNase was cheaper (P = 0.04) but was also associated with a higher rate of haemothorax (P = 0.002).
Conclusion:
In conclusion, treatment with urokinase is safer and equally effective when compared with treatment with t-PA/DNase. (PDT) . Recent data has suggested that durable disease control in MPM patients was associated to patient immunization against their cancer. Here we determined the immunological impact of low dose Visudyne (BPD-MA)-mediated PDT (L-PDT) in a syngeneic immunocompetent murine model of MPM. Methods: MPM AE17 cells were implanted in C57BL/6 mice (n = 24) and grown up to 30mm3 in volume. Animals were then separated into two treatment groups: L-PDT (BPD-MA 0.4 mg/kg i.v., 10J/cm 2 , 50 mW/cm 2 , drug-light interval 10 min, n = 12) and control (BPD-MA 0.4 mg/kg i.v., no light exposure, n = 12). Half of each treatment group was sacrificed at day 2 while the other half at day 7. Tumors were harvested and processed for analysis by 16-color flow cytometry to extract the tumor immune signature and determine its response to treatment. Results: We observed no difference in tumor size in this study between treatment groups. Multi-color flow cytometry analysis revealed a significant increase in the proportion of CD8+ T cells (CD8+CD3+, p < 0.05) as well as an enhanced activation of macrophages (p < 0.05), CD11b+ dendritic cells (p < 0.05) and of myeloid derived suppressor cells (mMDSCs, p < 0.05) two days after L-PDT compared to controls. Interestingly, seven days after L-PDT, while CD8+ T cells remained high (p < 0.05), the proportion of macrophages and of CD4+CD103+ cells went down (p < 0.05). In parallel, the activation status of CD11b+ dendritic cells and mMDSC were decreased (p < 0.05) while the activation status of macrophages was increased (p < 0.05). Conclusion: L-PDT created a marked modification of the immune signature of MPM that seem to favor a CD8+ cytotoxic T cell response. Further work combining this approach with immune checkpoint inhibition may help boost the impact of immunotherapy, particularly in tumors with low immunogenicity such as MPM.
Low dose photodynamic therapy promotes a cytotoxic immunological response in a murine model of malignant pleural mesothelioma
Objective: Stage IIIA-NSCLC includes a very heterogeneous group of patients depending on tumor localization, and extension of nodal disease. Therefore therapy still remains very controversial. The purpose of our study was to compare the survival between Stage IIIA subsets (T3N1 or T4N0/1 versus T1/2N2), and to validate our results with another center database. Methods: Between 2007 and 2017, 2057 patients completely resected for NSCLC were retrospectively analyzed. There were 424 patients who had Stage IIIA and 82 patients who had Stage IIIB (T3/4N2). Stage IIIA patients were divided into two subsets according to tumor localization (T3N1 and T4N0/1, IIIA-T group; n = 308) and extension of nodal disease (T1/2N2, IIIA-N2 group; n = 116). Age, gender, pack/years, and comorbidity did not differ between subsets. Another Thoracic Surgery Center cancer database was used for validation. Results: IIIA-N2 group had more adenocarcinoma than IIIA-T group (52.6% vs 29.5%, p < 0.001), and pneumonectomy was more performed in IIIA-T group (51.0% vs 32.8%, p = 0.001). In multivariate analysis, N2 and age > 65 were significant independent negative prognostic factors (p < 0.001). Five-year survival for patients in IIIA-T group was 51.3% (median 64 months), whereas it was 25.7% (median 31 months) for IIIA-N2 patients (HR: 1.834, 95%CI [1.345-2.501], p < 0.0001) (Figure 1 ). There was no statistically difference regarding the survival between IIIA-N2 and Stage IIIB (25.7% vs 25.3%, p = 0.4). According to the results, we performed a re-staging for Validation Cohort patients as; Stage IIIA-T (including T3N1 and T4N0/1) (n = 139), Stage IIIA-N (including T1/2N2) (n = 104), and Stage IIIB (n = 50). Stage IIIA-T had a statistically better survival than Stage IIIA-N (50.5% vs 27.1%, HR: 1.707, 95%CI [1.231-2.366], p = 0.0007), whereas five-year survival rates were similar for Stage IIIA-N and Stage IIIB (27.1% vs 27.1%, p = 0.9) ( Figure 2) . Conclusion: Since our results were validated with another center database, we propose that stage IIIA should be divided into two different subgroups according to the primary tumor extension (T) and mediastinal lymph node involvement (N) in the next TNM classification. Objective: Distal radius and ankle fractures are one of the most common operatively treated fractures. To date, there is no consensus concerning the need for a standard postoperative radiograph. This leads to undesirable practice variations. If standardized intraoperative radiographs have been obtained, it is questionable if these postoperative radiographs are necessary and will lead to changes in the treatment strategy. If standard postoperative radiographs are no longer required, this would lead to a reduction in radiation exposure and health care costs. The hypothesis is that routine standardized postoperative radiographs do not influence the quality of care for patients operated on for either a distal radius or an ankle fracture if adequate intraoperative standardized radiographs have been obtained.
The impact of patient compliance and individual components in an
The primary aim of this study is to evaluate if there is a need for routine postoperative radiographs after an osteosynthesis of a distal radius or ankle fracture. Methods: In a prospective, randomized controlled, open label trial based on a non-inferiority design, we enrolled 332 patients. The control group was treated according to our current, standard protocol in which all patients received a standard anterior-posterior and lateral radiograph on the first postoperative day. Patients randomized to the intervention group were treated without a standard postoperative radiograph. All patients (n = 332) had a routine clinical and radiographic control after 6 weeks in the outpatient clinic. Primary outcome is a change in treatment plan, defined as either additional imaging or a reoperation based on the intraoperative or postoperative imaging. Results: The trial started in August 2016 and ended in September 2018. 445 patients were screened, 332 were included. In the control group 4 out of 155 (2.6%) had an additional imaging or a reoperation, in the intervention group 8 out of 164 (4.9%) had a change in treatment plan. Statistically there is a non inferiority of the intraoperative radiographs compared to the additional postoperative radiographs. Conclusion: Our findings prove that there is no need for postoperative radiographs if the intraoperative radiographs are adequate. This may lead to a strong reduction in radiation exposure and health care costs. A preliminary, conservative estimation suggests a yearly cost saving of CHF 1.3 million in Switzerland.
Conventional fluoroscopy-guided percutaneous placement of iliosacral screws in the era of intraoperative 3D imaging and navigation: inappropriate or still a valid option?
H. Kuttner, E. Benninger, C. Meier
Department of Orthopedics and Traumatology, Cantonal Hospital Winterthur, Winterthur, Switzerland
Objective: The percutaneous placement of iliosacral screws (ISS) is an established technique for the fixation of posterior pelvic ring injuries. The anatomy of the sacrum is complex and the landmarks may be difficult to identify with conventional fluoroscopy, particular in osteoporotic bone or in the presence of interfering bowel gas. Malpositioning of ISS is a complication with potential injury to adjacent neurovascular structures. Thus, computer navigated screw insertion has gained increasing popularity. It was the aim of this study to evaluate the quality of conventional fluoroscopy-guided percutaneous placement of ISS. Methods: In 2017, the surgical procedure was standardized following a step by step technique using conventional intraoperative fluoroscopy. All procedures between 01/2017 and 12/2018 were included. All patients underwent computed tomography (CT) for fracture analysis and preoperative planning. Surgery was performed percutaneously in supine position. Following the standardized procedure, a postoperative CT was performed to confirm proper screw position. The screw position was defined to be either correct or with tangential involvement or true hit of the neuroforamina or spinal canal, or with anterior or superior bone perforation. Postoperative complications and revision surgeries were recorded as well. Results: Median age was 78 years (range 16-91 years). In total, 50 ISS were inserted in 26 patients, 32 ISS into S1 and 18 into S2, respectively. In a 16 year old patient, 2x6.5 cannulated screws were used, all other patients received 7.3 cannulated screws. Regarding S1, malposition was observed for 2 ISS (6%), of these, 1 (3%) with tangential involvement of the spinal canal and 1 (3%) anterior bone penetration. For S2, tangential involvement of the spinal canal was seen for 3 (17%) ISS. Screw malposition did not cause any neurovascular complications. Early migration resulted in screw exchange in 1 case (2%) and another 2 ISS had to be removed prematurely due to symptomatic loosening (4%). Conclusion: Following a standardized step by step surgical technique, conventional ISS placement is reliable and safe. Due to the smaller dimensions, ISS malposition was more frequently observed in S2 than in S1. However, only tangential involvement of the spinal canal occurred and no neurovascular complications were seen. Objective: Primary Total Elbow Arthroplasty (TEA) is an option in the treatment of acute distal humerus fractures in the elderly. Results comparable to ORIF have been reported. However, loading of the upper extremity after TEA must be restricted which may limit activities of patients who use their upper limb as a walking aid. Hemiarthroplasty is an alternative in the fracture situation where the proximal forearm is not involved. If the elbow is stable (healed epicondyles), the extremity can be used without limitations. Methods: Between 4/2017 and 7/2018 we have used Elbow Hemiarthroplasty (Latitude, Fa. Wright/Tornier) as a primary treatment in 6 consecutive elderly female patients (70-88y) with extremely low distal humerus fractures that seemed not to be amenable to ORIF . Routine radiological follow up was performed at 6 and 12 weeks and at latest follow up. Clinical outcome was documented with ROM, pain VAS, a Subjective Elbow Value (SEV), Quick-DASH, Oxford Elbow Score, and Mayo Elbow Performance Score. Suhm's scale was used to assess any change in self-dependency. Results: There were no implant related complications or infections. All epicondyles healed with a stable elbow except one with a slight medial opening that was asymptomatic. One patient who had a delayed initial operation (2 weeks post trauma) needed a revision operation (arthrolysis and removal of periarticular ossifications) 6 months after the index procedure due to stiffness. The remaining had a subjectively satisfactory result (SEV 80-100%), ROM > 100 ∘ and good to excellent clinical scores ratings. 4/6 used a walking aid (Rollator), all returned to their premorbid social environment. Conclusion: Elbow Hemiarthroplasty appears to be a valuable option in the treatment of difficult distal humerus fractures in the elderly. Compared to Total Elbow Arthroplasty restrictions in loading the extremity are not necessary which is an advantage for patients who use their upper limb for walking aids. Long term results are needed.
Elbow hemiarthroplasty for selected distal humerus fractures in the elderly: a preliminary report
hypothesize that patient and physician satisfaction will increase when physician have more time available for direct patient contact. Methods: A scribe program was implemented on the emergency department during labour-intensive periods, that are typically outside office hours and therefore difficult to cover by secretaries. We performed a quasi-experimental prospective cohort study, measuring time used for documentation as a primary endpoint. Physician productivity in terms of time, and patients / physician satisfaction, quantified using Likert-Type scales, were used as secondary endpoints. A total of 10 physicians and 2 medical scribes took part in the study. Scribes were trained for 1 month before data recording. Results: In our data so far, we observed a significant reduction of the time passed in front of the computer for documentation, including reports writing, from 55.3% ± 2.6% without a medical scribe to 33.2% ± 4.8% with a medical scribe (p = 0.0145, Mann-Whitney test). Time passed with the patient was increased from 18.5% ± 2.2% to 46.2% ± 3.2% (p = 0.0012, Mann Whitney test). We observed no difference in the time used for patient care that were 13.87% ± 5% and 11.52% ± 2.9% (p = 0.6838, Mann Whitney test). Results from questionnaires are still in progress. The number of patients seen by the doctors was not controlled. Conclusion: Our preliminary data indicate that medical scribes reduce the administrative burden for the assistant physician in the emergency department and increase valuable time with the patient. We expect that this will have a positive impact on patient and physician satisfaction too.
→ zurückgezogen, da inzwischen in einem anderen Magazin publiziert
Simple correction technique of femoral malrotation after PFN -A osteosynthesis of trochanteric fracture K. Pavotbawan, P. Stillhard, C. Sommer
Department of Surgery, Trauma Surgery Unit, Cantonal Hospital Graubünden, Chur, Switzerland
Objective: Malrotation after intramedullary nailing in femoral shaft fractures are well known. But malrotation after nailing of trochanteric fractures is, in our view, an underestimated problem. During surgery the axial alignment can easily be evaluated by fluoroscopy in both planes. But the torsional alignment is difficult to assess especially with the patient placed on the traction table. In the literature a malrotation after PFNA is described in up to 25% of the cases. A revision with replacement of the blade, especially in patients with poor bone quality, may result in a reduced stability. To our knowledge there is no publication till to date to give a treatment pathway for this problem. We developed a rather easy technique to derotate a malrotated femur after PFNA fixation. Methods: The basic idea of our technique is to leave the usually well placed blade in situ in the femoral head, just rotating the distal main fragment around the nail. To be able to do this, a small U-shaped osteotomy with a chisel is performed in the femoral cortex just anterior of the entry site of the blade. The length (l) of this osteotomy can be calculated, following the formula: l = d x π x α/360 (d = diameter of femur, α = angle of malrotation). Then the distal locking bolt is removed, the leg derotated externally and finally locked again. The procedure is controlled by two Schanz'screws separately inserted in both main fragments angulated to each other in the angle "α". Results: Since 2014 three patients were detected with a clinically relevant malrotation after PFNA for trochanteric fracture. All patients had an internal malrotation from 30 to 40 degrees confirmed and measured by CT scan. All of them were successfully revised in the above described technique 5 to 9 days after initial fixation. The postoperative course was in all patients without complication. Conclusion: First, we believe that malrotation after trochanteric fracture fixation is an underestimated problem. And second our method is a simple salvage procedure for malrotated trochanteric fractures after PFNA, leaving the blade in situ in the femoral head. the use of (M)GAP would have missed one patient (undertriage 0.6%), whereas 766/2112 patients (overtriage 42%) would be unnecessarily treated in the ER. With respect to the ER selection criterion ISS > 15 or need of trauma centre resources (ICU, emergency surgery, intubation) the (M)GAP showed overand undertriage rates ranging between 32-39% and 18-32%, respectively. In comparison, the proposed ERTAA criteria predicted mortality with an underand overtriage of 1.7% and 69%. For the ER selection criterion ISS > 15 or need of trauma centre resources under-and overtriage ranged between 2-9% and 61-65%, respectively. Conclusion: This Swiss trauma centre investigation confirmed the precision of the (M)GAP tools in the prediction of hospital mortality for ER trauma patients. Even though, in the preclinical decision process for trauma centre need, their clinical benefit demonstrated to be inferior to proposed ERTAA criteria, due to unacceptably high undertriage rates for patients with potential severe injury and need for subsequent therapy. Therefore, more extensive ERTAA cannot be substituted by simpler scores such as the (M)GAP.
